🇺🇸 FDA
Patent

US 11179435

Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient

granted A61KA61K31/36A61K38/08

Quick answer

US patent 11179435 (Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient) held by CAREGEN CO., LTD. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/36, A61K38/08, A61K38/10, A61K47/44